Loading song details...
Pedro Barata MD Highlights Phase 3 Data On 177Lu Rosopatamab Tetraxetan In MCRPC
No description available.
MP3 Download
Video Download
Related Songs
10:29
Dr Pedro Barata On ARCC Diagnosis Treatment Options And Progression After ICI Combinations
4:25
Uromigos Live 2023 Dr Pedro Barata On Cisplatin For Bladder Cancer
6:29
Dr Pedro Barata On Improving Outcomes For Patients With ARCC Who Progress Initial ICI Treatment
3:23
Pedro Barata MD Highlights Phase 3 Data On 177Lu Rosopatamab Tetraxetan In MCRPC
1:17
Dr Pedro Barata Hematology And Oncology
17:02
Dr Pedro Barata Overview Of FOTIVDA Tivozanib
1:01
Tulane Doctors Health Minutes Pedro Barata MD MSc
58:31
The Latest Evidence Based Guidance For Management Of RCC By Pedro C Barata MD MSc
8:52
MedJ Interview Prof Pedro Barata Discusses 177Lu Rosopatamab Safety Data In MCRPC
5:16
Differences In Genomic Landscape Between African Americans And Caucasians With Prostate Cancer
2:09
The Expanding PSMA Targeted Therapy Landscape In Prostate Cancer
1:41
What Communities Are Affected By Renal Medullary Carcinoma
3:00
Exclusive Highlights In Genitourinary Cancer At ASCO 2023
10:10
Treatment Intensification SPOP Gene Alterations In Advanced Prostate Cancer
11:33
Advancing Treatment Strategies In MHSPC Addressing Disparities And Optimizing Care
1:16
What Is Renal Medullary Carcinoma
13:31
Enhancing Genetic Testing Rates In Metastatic Prostate Cancer Trends Challenges And Opportunities
4:35
Dr Pedro Barata On Sequencing Therapies And Other Treatment Considerations For ARCC
1:44
Immune Checkpoint Inhibitors In MCRPC
5:32